Harvard Class of ’18 Yield Remains 82 Percent

With early-action acceptances high, few chances for wait-listed applicants

Harvard College announced today that nearly 82 percent of the 2,023 candidates offered admission to the class of 2018 had accepted—meaning that the waiting list will again go essentially untapped, with just 15 to 20 applicants ultimately admitted. The “yield” was 82 percent last year, and 81 percent the prior year: historically high figures, reflecting, in part, the reinstatement of early-action admissions. Typically, early-action applicants are thought to be very strongly inclined to attend the institution to which they apply; as reported last December, 992 applicants using the early-action deadline were offered admission to the class of 2018, likely filling well more than half the cohort expected to enter the College this coming August.

According to the news release, "The class will have a record number of African-Americans (177) and Latinos (185), as well as the second-largest number of Asian-Americans (351) in Harvard’s history."

Read the release here.

You might also like

Historic Humor

University Archives to preserve Harvard Lampoon materials

Academia’s Absence from Homelessness

“The lack of dedicated research funding in this area is a major, major problem.”

The Enterprise Research Campus, Part Two

Tishman Speyer signals readiness to pursue approval for second phase of commercial development.  

Most popular

Poise, in Spite of Everything

Nina Skov Jensen ’25, portraitist for collectors and the princess of Denmark. 

Renovating Gund

Renovations on Gund Hall of Harvard Graduate School of Design (GSD) to be completed by next year. 

Claudine Gay in First Post-Presidency Appearance

At Morning Prayers, speaks of resilience and the unknown

More to explore

Exploring Political Tribalism and American Politics

Mina Cikara explores how political tribalism feeds the American bipartisan divide.

Private Equity in Medicine and the Quality of Care

Hundreds of U.S. hospitals are owned by private equity firms—does monetizing medicine affect the quality of care?

Construction on Commercial Enterprise Research Campus in Allston

Construction on Harvard’s commercial enterprise research campus and new theater in Allston